Abstract
The nitroblue-tetrazolium test was performed on a group of uræmic patients and a group of renal transplant patients in an attempt to assess its ability to identify bacterial infection. The data suggest that this test is useful in monitoring the infectious-disease status of uræmic patients. The test is not affected by large doses of steroids nor by transplant rejection, and is therefore useful in the diagnosis and differential diagnosis of infection and/or rejection in the transplant patient.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have